I have written about MFS Intermediate Income Fund (MIN) on a few previous occasions, most recently here. I have extolled its virtues as a defensive play in a bear market scenario.
In this brief article, I wish to provide an update on MIN's recent release of its breakdown of the May monthly dividend, which to me shows a change in its income sources.
MIN is high on my watch list, as it certainly appears that the markets could be turning down as this is written. At a minimum, volatility seems to be increasing, particularly when one notes how the market averages had some pretty wild swings last week.
A Quick Summary Of MIN
MIN is a closed-end fund [CEF] that seeks to provide income by investing in short and mid-term high grade securities. Its portfolio is global in scope.
Of late, MIN's performance has been abysmal at best, with both its price per share and net asset value [NAV] hitting new lows on an almost a daily basis. At its Friday closing price of $5.70 the current yield is now 9.07%. On the encouraging side (really encouraging) is the fact that MIN is now selling at a 4.52% discount to NAV. MIN has only sold at a discount two times in the past year, and to my knowledge both times the discount was very small.
Hot Building Product Stocks To Watch For 2015: BioMarin Pharmaceutical Inc.(BMRN)
BioMarin Pharmaceutical Inc. develops and commercializes biopharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and rest of the world. The company?s commercial products include Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase enzyme used for the treatment of mucopolysaccharidosis (MPS) VI; Kuvan, a proprietary synthetic oral form of 6R-BH4 used to treat patients with phenylketonuria (PKU), a metabolic disease; Aldurazyme used for the treatment of mucopolysaccharidosis I, a genetic disease; and Firdapse used to treat Lambert Eaton Myasthenic Syndrome, an autoimmune disease. It develops GALNS, an enzyme replacement therapy for the treatment of MPS IVA, a lysosomal storage disorder; PEG-PAL, an enzyme substitution therapy that is under Phase II clinical trial to treat PKU; BMN-673, a Phase I/II clinical trial product for the treatment of cancer; BMN-701, an enzyme replacement therapy, which is under Phase I/II clinical trials for Pompe disease, a glycogen storage disorder; and BMN-111, a peptide therapeutic that is under Phase I clinical trial for the treatment of achondroplasia. The company sells its Naglazyme, Kuvan, and Firdapse products to specialty pharmacies and end-users, such as hospitals and foreign government agencies, which act as retailers; and Naglazyme products to distributors and pharmaceutical wholesalers. It has a collaboration agreement with Genzyme Corporation for the manufacture of Aldurazyme; and an agreement with Merck Serono S.A. for the further development and commercialization of Kuvan and other products containing 6R-BH4 and PEG-PAL for PKU. BioMarin Pharmaceutical Inc. was founded in 1996 and is headquartered in Novato, California.
Advisors' Opinion:- [By Sean Williams]
BioMarin Pharmaceuticals (NASDAQ: BMRN )
BioMarin might as well be considered a long lost sibling of Alexion, since they are both focused on developing rare orphan drugs which have practically no competition and hefty annual price tags, often in six-figures. However, whereas Alexion is profitable, BioMarin has some "'splaining to do," as Desi Arnaz used to say. Estimates in the upcoming quarter call for sales growth of just 8% to $134 million with losses expected to widen to $0.29 per share. Naglazyme's 1% sales increase last quarter didn't impress at all, so it'll need Aldurazyme to really step up if it hopes to maintain its frothy valuation. - [By Monica Gerson]
BioMarin Pharmaceutical (NASDAQ: BMRN) shares moved up 1.48% to $78.64. The volume of BioMarin Pharmaceutical shares traded was 966% higher than normal. BioMarin shares jumped on Roche Holding (OTC: RHHBY) takeover report..
- [By Lauren Pollock]
BioMarin Pharmaceutical Inc.(BMRN) said a U.S. Food and Drug Administration advisory panel recommended approval of the company’s enzyme-replacement therapy for patients with a rare inherited disorder that can hinder growth. In premarket trading, shares rose 5.7% to $70.75.
- [By Ben Levisohn]
Sure Intercept Pharmaceuticals (ICPT) might feel like the only biotech stock that matters today, but there are others. For instance, Incyte (INCY) and� BioMarin (BMRN) are on the move after Barclays changed its ratings on the pair.
Best Defensive Companies To Invest In Right Now: IsoRay Inc (ISR)
IsoRay, Inc. (IsoRay), incorporated on June 15, 2004, develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. IsoRay International LLC (International) is a wholly owned subsidiary of the Company. IsoRay obtained clearance from the Food and Drug Association (FDA) for treatment for all solid tumor applications using Cesium-131. Such applications include prostate cancer; ocular melanoma; head, neck and lung tumors; breast cancer; liver cancer; brain cancer; colorectal cancer; gynecological cancer; esophageal cancer, and pancreatic cancer. The seed may be used in surface, interstitial and intracavity applications for tumors with known radio sensitivity. The Company has an existing distribution agreement with UralDial LLC (UralDial) that allows UralDial to distribute Proxcelan Cs-131 brachytherapy seeds in Russia. The Company, through UralDial, has regulatory approval to sell Cs-131 seeds in Russia.
IsoRay markets the Proxcelan Cesium-131 brachytherapy seed for the treatment of prostate cancer; lung cancer; ocular melanoma; head and neck cancers; colorectal cancer, brain cancer; and gynecological cancer. The Company focuses to market Cesium-131 for the treatment of other malignant disease, such as breast cancer, in the near future through the use of existing technologies that have received FDA-clearance. Cesium-131 is a radioactive isotope that can be produced by the neutron bombardment of Barium-130 (Ba-130). When placed into a nuclear reactor and exposed to a flux of neutrons, Ba-130 becomes Ba-131, the radioactive material that is the parent isotope of Cesium-131. The radioactive isotope Cesium-131 is normally produced by placing a quantity of stable non-radioactive barium (ideally barium enriched in isotope Ba-130) into the neutron flux of a nuclear reactor. The irradiation process converts a small fraction of this material into a radioactive form of barium (Ba-131). The Ba-131 decays by electron capture to the ! radioactive isotope of interest (Cesium-131).
As of June 30, 2011, IsoRay had agreements with several independent radiopharmacies to assay, preload, and sterilize loose seeds. During the fiscal year ended June 30, 2011, the Company loaded approximately 90% of Mick cartridges in the Company's own facility, which accounted for approximately 61% of seeds sold. Approximately 33% of seeds sold are strand configurations, including strands preloaded in needles and the remaining 6% of seeds are sold as loose seeds.
Advisors' Opinion:- [By Vanina Egea]
Strengthening portfolio and business stability is to be reinforced by the introduction of new products. Last December, Textron announced the successful first flight of the Scorpion Intelligence, Surveillance and Reconnaissance (ISR)/Strike aircraft. ��he Scorpion compares very favorably to more costly aircraft currently used for low-threat missions,��pilot Dan Hinson said. The new product is expected to accommodate the budget constraints and shifting mission requirements of the US Department of Defense. The same department has granted the firm an additional contract worth $22.5 million to "deprocess" Mobile Strike Force vehicles and train the Afghan Army.
- [By James E. Brumley]
Ugh. It's fun to be right about a stock, but it's exhausting to be too right, too fast. Case in Point? IsoRay, Inc. (NYSE: ISR). Yours truly posted some bullish comments on ISR just a couple of days ago, explaining how that day's move above a key ceiling meant a new bull trend was underway, and more gains from that price would be far easier to muster. Well, good news for those who heeded the advice - IsoRay shares are up 44% today.
- [By James E. Brumley]
I hate to be the one to say I told you so, but, I told you so. Back on February 26th I suggested IsoRay, Inc. (NYSEMKT:ISR) shares were a budding breakout play. The 48% rally that's played out for ISR in the meantime unfurled right on cue. While overbought in the very short run, this small cap stock looks like it's earning the right to be compared to the likes of bigger brothers in the cancer-treatment space... names like Roche Holding Ltd. (OTCMKTS:RHHBY) or Theragenics Corporation (NYSE:TGX).
Best Defensive Companies To Invest In Right Now: Graham Corp (GHM)
Graham Corporation (Graham), incorporated on March 7, 1983, designs, manufactures and sells critical equipment for the energy industry which includes the oil refining, petrochemical, as well as cogeneration, nuclear and alternative power markets. It design and manufacture custom-engineered ejectors, pumps, surface condensers and vacuum systems as well as supplies and components for inside the reactor vessel and outside the containment vessel of nuclear power facilities. Its equipment is also used in nuclear propulsion power systems for the defense industry and can be found in other diverse applications such as metal refining, pulp and paper processing, water heating, refrigeration, desalination, food processing, pharmaceutical, heating, ventilating and air conditioning. The Company�� two wholly owned subsidiaries include Graham Vacuum and Heat transfers Technology (Suzhou) Co., Ltd.
The Company's products are used in a range of industrial process applications, including Chemical and Petrochemical Processing, such as ethylene, methanol and nitrogen producing plants, plastics, resins and fibers plants and petrochemical intermediate plants, and Power Generation /Alternative Energy, such as propulsion systems for nuclear-powered aircraft carriers and other nuclear- powered vessels, air conditioning and water heating systems and liquefied natural gas production facilities. The Company's principal customers are in the chemical, petrochemical, petroleum refining and power generating industries, and are users of the Company's products in their manufacturing, refining and power generation processes, large engineering companies that build installations for companies in such industries, and/or the original equipment manufacturers, who combine its products with their equipment prior to its sale to end users.
The Company competes with Gardner Denver, Inc., GEA Wiegand GmbH, Edwards, Ltd, Korting Hannover AG, Croll Reynolds Company, Inc, Schutte Koerting, Gardner Denver, Inc, DongHwa En! tec Co., Ltd, Hangzhou Turbine Equipment Co., Chem Process Systems, Mazda (India), Oeltechnik GmbH, KEMCO, Holtec, Thermal Engineering International, SPX Heat Transfer, Chem Process Systems, Mazda (India)., Ambassador, Alfa Laval AB, APV, Xylem, Dubose, Consolidated, Tioga, Nova, Joseph Oats and Energy & Process.
Advisors' Opinion:- [By Rick Munarriz]
Friday
The market is typically quiet on Friday, but don't tell that to Graham (NYSEMKT: GHM ) . The maker of custom-engineered ejectors, pumps, condensers, vacuum systems, and heat exchangers reports on Friday morning. Analysts see profitability almost quadrupling to $0.31 a share, and revenue soaring 48%.
Best Defensive Companies To Invest In Right Now: Burnham Holdings Inc (BURCA)
Burnham Holdings, Inc., incorporated on December, 2, 2002, is the parent company of the Burnham group of companies. The Company is a manufacturer of boilers, furnaces, radiators, air conditioning systems and related accessories for residential, commercial, and industrial applications. The Company has eight brand names, marketed through eight independent sales organizations that are differentiated by product line and markets served. The Burnham Hydronics, New Yorker, Governale, Thermo Pride, and Crown product lines offer a range of cast iron, stainless steel, aluminum, and steel boilers, cast iron and steel heat distribution products, warm air furnaces, heat pumps and central air conditioning systems for the residential heating and cooling market. Typical applications of these products are for all styles and sizes of homes and small buildings. The Burnham Commercial, Bryan Boilers, and Thermal Solutions product lines offer a range of cast iron, firetube, watertube, and copper tube boilers, as well as boiler room accessories for the commercial and industrial markets. Typical uses of these products are for heating large buildings and high-pressure steam generation for process applications.
The Burnham Foundry produces boiler castings for the affiliated manufacturing companies, as well as outside customers. Wendl and Manufacturing is a producer of both pressurized and non-pressurized tanks and vessels for liquid storage applications. Norwood Manufacturing is a manufacturer of painted light gauge metal parts. The Company sells to wholesale distributors who in turn, market to builders, heating contractors, utilities, and fuel dealers for resale to end-use customers.
Advisors' Opinion:- [By Marc Bastow]
Boiler, radiator, air conditioning and furnace manufacturer Burnham Holdings (BURCA) raised its quarterly dividend 11% to 21 cents per share, payable March 18 to shareholders of record as of March 11.
BURCA Dividend Yield: 4.3%
Best Defensive Companies To Invest In Right Now: UnitedHealth Group Incorporated(UNH)
UnitedHealth Group Incorporated provides healthcare services in the United States. Its Health Benefits segment offers consumer-oriented health benefit plans and services to national employers, public sector employers, mid-sized employers, small businesses, and individuals; and non-employer based insurance options for purchase by individuals. It also provides health and well-being services for individuals aged 50 and older; and for services dealing with chronic disease and other specialized issues for older individuals, as well as health plans for the beneficiaries of acute and long-term care Medicaid plans. This segment offers its services through a network of 730,000 physicians and other health care professionals, and 5,300 hospitals. Its OptumHealth segment provides health, financial, and ancillary services and products that assist consumers through personalized health management solutions; benefit administration, and clinical and network management; health-based financi al services; behavioral solutions; and specialty benefits, such as dental, vision, life, critical illness, short-term disability, and stop-loss product offerings. The company?s Ingenix segment offers database and data management services, software products, publications, consulting and actuarial services, business process outsourcing services, and pharmaceutical data consulting and research services. Its Prescription Solutions segment provides integrated pharmacy benefit management services comprising retail network pharmacy contracting and management, claims processing, mail order pharmacy services, specialty pharmacy, benefit design consultation, rebate contracting and management, drug utilization review, formulary management programs, disease therapy management, and adherence programs to employer groups, union trusts, managed care organizations, Medicare-contracted plans, Medicaid plans, and third party administrators. The company was founded in 1974 and is based in Minne tonka, Minnesota.
Advisors' Opinion:- [By Amanda Alix]
It's a beautiful day for the Dow Jones Industrial Average (DJINDICES: ^DJI ) so far, as the index continues its climb following some excellent news on the trade deficit and a sweet upgrading of health insurer UnitedHealth Group (NYSE: UNH ) from Deutsche Bank.
- [By Keith Speights]
Quality Software Services, which is owned by UnitedHealth Group (NYSE: UNH ) , was the contractor to which Campbell alluded. However, a key link in the component that Quality Software Services developed came from Oracle (NYSE: ORCL ) . Early finger-pointing suggested that the Oracle Identity Manager was a cause of the major technical problems. That prompted Oracle to strongly deny that its software wasn't working.
Best Defensive Companies To Invest In Right Now: Graham Holdings Co (GHC)
Graham Holdings Company, formerly The Washington Post Company, incorporated on July 21, 2003, is a diversified education and media company whose principal operations include educational services, television broadcasting, cable television systems, and online, print and local TV news. The Company owns Kaplan, a provider of educational services to individuals, schools and businesses, serving over one million students annually with operations in more than 30 countries. Its programs include higher education, test preparation, language instruction and professional training. Its Post-Newsweek Stations, Inc owns six television stations which include WDIV-Detroit (NBC), KPRC-Houston (NBC),WPLG-Miami (ABC), WKMG-Orlando (CBS), KSAT-San Antonio (ABC) and WJXT-Jacksonville (independent). The stations also broadcast digital channels focusing on classic television and lifestyle programming, in addition to operating websites, mobile sites and mobile apps delivering breaking news, weather and community news. Its Cable ONE, headquartered in Phoenix, AZ, serves small-city subscribers in 19 midwestern, western and southern states. Cable ONE provides digital video, Internet and phone service to homes and businesses. The Company�� Slate Group is a daily online magazine that offers fresh angles on stories in the news and entertainment coverage, all with its signature wit and irreverence, publishing provocative commentary on topics such as politics, culture, business and technology. Slate V is a daily online video magazine offering original video about politics, culture, and business, technology.
The Company divested its interest in Avenue100 Media Solutions Inc., a digital marketing company headquartered in Woburn, Massachusetts, in 2012. The Company sold its interest in the Bowater Mersey Paper Company Limited to the Province of Nova Scotia in 2012. In March 2013, the Company announced it has completed the sale of The Herald, a daily and Sunday newspaper and its other print and online products to Sound Publ! ishing, Inc.
Education
Kaplan, Inc., a subsidiary of the Company, provides a range of education and related services worldwide for students and professionals. Kaplan conducts its operations through three segments: Kaplan Higher Education, Kaplan Test Preparation and Kaplan International. Kaplan Higher Education (KHE) provides a wide array of certificate, diploma and degree programs on campus and online designed to meet the needs of students seeking to advance their education and career goals. During the year ended December 31, 2012, Kaplan�� United States-based KHE division businesses include Kaplan University and KHE Campuses.
Kaplan University specializes in online education, is accredited by the Higher Learning Commission of the North Central Association of Colleges and Schools and holds other programmatic accreditations. Kaplan University�� programs are offered online, while some are offered in a traditional classroom format at 12 campuses in Iowa, Maine, Maryland and Nebraska, and four Kaplan University Learning Centers in four additional states. Kaplan University also includes Concord Law School, a fully online law school. During 2012, Kaplan University had approximately 38,800 students enrolled in online programs and approximately 5,600 students enrolled in its classroom-based programs.
Also residing within Kaplan University is the School of Professional and Continuing Education (PACE). PACE offers a range of education solutions to assist professionals in advancing their careers by obtaining professional licenses, designations and certifications. This includes solutions for insurance, securities, real estate, mortgage and appraisal licensing exams and for advanced designations, such as CFA and CPA exams. PACE serves more than 2,900 business-to-business clients, including more than 70 Fortune 500 companies. In 2012, approximately 510,000 students used PACE's exam preparation offerings. As of December 31, 2012, the KHE Campuses business consis! ts of 59 ! schools in 17 states, which provides classroom-based instruction to approximately 21,100 students.
Kaplan International operates businesses in Europe and the Asia Pacific region. In Europe, Kaplan operates in the businesses, which are all based in the United Kingdom and Ireland: Kaplan UK, Kaplan International Colleges (KIC) and a set of higher education institutions. The Kaplan United Kingdom business in Europe is a provider of training, test preparation services and degrees for accounting and financial services professionals, including those studying for ACCA, CIMA and ICAEW qualifications. In addition, Kaplan United Kingdom provides legal and professional training, including the operation of a United Kingdom law school in collaboration with Nottingham Trent University�� Nottingham Law School. In 2012, Kaplan United Kingdom provided courses to approximately 66,000 students, of whom 49,000 were dedicated to accounting and financial services coursework.
The KIC business consists of university pathways business and an English-language training business. The university pathways business offers academic preparation programs especially designed for international students who wish to study in English-speaking countries. KIC operates university pathways programs in collaboration with nine U.K. universities. As of December 31, 2012, KIC�� university pathways business was serving approximately 2,700 students. The English-language business (previously operated as Kaplan Aspect) provides English-language training, academic preparation programs and test preparation for English proficiency exams, principally for students wishing to study and travel in English-speaking countries. KIC operates a total of 41 English-language schools, with 19 located in the United Kingdom, Ireland, Australia, New Zealand and Canada, and 22 located in the United States, where they operate under the name Kaplan International Centers. During 2012, the English-language business served approximately 65,000 stud! ents.
!Kaplan also operates three higher education institutions in Europe, located in the United Kingdom and Ireland. These institutions are Dublin Business School, Holborn College and Kaplan Open Learning. As of December 31, 2012, these institutions enrolled an aggregate of approximately 6,500 students. In the Asia Pacific region, Kaplan operates businesses in Singapore, Australia, Hong Kong and China. In Singapore, Kaplan operates three business units, Higher Education, Financial and Professional, which serve more than 16,700 students from various countries throughout Asia.
Kaplan Singapore�� Higher Education business provides students with the opportunity to earn bachelor�� and postgraduate degrees in various fields on either a part-time or full-time basis. Kaplan Singapore�� students receive degrees from affiliated educational institutions in Australia, the U.K. and the U.S. In addition, this division offers pre-university and diploma programs. Kaplan Singapore�� Financial business provides preparatory courses for professional qualifications in accountancy and finance, such as the Association of Chartered Certified Accountants (ACCA) and the Chartered Financial Analyst (CFA).
In Australia, Kaplan delivers a broad range of financial services education and professional development courses. In 2012, this business provided courses to approximately 17,400 students through classroom programs and to more than 44,800 students through distance-learning programs. In 2012, Kaplan Australia underwent operational restructuring and offers its programs through three business units: English Language and Pathways; Vocational Education; and Higher Education.
The Vocational Education business of Kaplan Australia includes Kaplan Professional Education (KPE), Carrick Education Group and Franklyn Scholar. KPE offers financial services education programs and continuing professional development courses primarily to a business-to-business market, including banks and numerous! industry! sectors.. Approximately 43,000 students are taught through KPE each year. Carrick has traditionally offered English-language programs, vocational training and higher education courses in Australia. Kaplan is evaluating various strategic alternatives with respect to the Carrick business lines. As of December 31, 2012, Carrick was providing services to approximately 1,300 students. Franklyn Scholar offers a wide range of custom-developed programs to business clients. More than 16,000 students are taught through Franklyn Scholar each year.
The higher education business of Kaplan Australia comprises Kaplan Online Higher Education (KOHE) and Kaplan Business School (KBS), which offers diploma, bachelor�� and master�� degree programs. As of December 31, 2012, KBS has opened a new school in Brisbane and operates in four states in Australia teaching approximately 700 students each year. KOHE teaches approximately 1,800 students annually in postgraduate courses primarily in the financial services sector.
In Hong Kong, Kaplan offers a comprehensive array of programs, ranging from language education and standardized test preparation to corporate and financial training and higher education degree courses. During 2012, Kaplan�� Hong Kong business provided courses to more than 15,700 students.
In China, Kaplan provides foundation programs to Chinese students through partnerships with prestigious Chinese universities and high schools. Kaplan China offers foundation programs at 11 campuses and had more than 1,100 students enrolled at the end of 2012. Kaplan China also cooperates with several Chinese universities to provide ACCA training programs to the students. Cable ONE offers broadband Internet access service on virtually all of its cable systems and is the sole Internet service provider on those systems.
Kaplan International also includes the Kaplan Global Solutions business unit, which continues to develop partnerships with colleges, universities and non-p! rofit corp! orations and foundations. Kaplan Global Solutions, through its Colloquy business, enables its university partners to develop online educational programs by providing an array of research, marketing and design services. Through its Global Pathways programs, Kaplan Global Solutions enables its partner institutions in the Americas to enhance their brand globally and increase international student enrollments by designing and marketing custom programs aimed at student success.
Cable Television Operations
Through its subsidiary Cable One, Inc. (Cable ONE), the Company owns and operates cable television systems that provide video, Internet and voice service to subscribers in 19 midwestern, western and southern states. At the end of 2012, Cable ONE provided cable service to approximately 593,600 video subscribers, representing about 41% of the 1,439,740 homes passed by the systems, had approximately 459,200 subscriptions to high-speed data (HSD) service and 184,500 subscriptions to VoIP (digital voice) service. The video services offered by Cable ONE include certain premium, cable network and local over-the-air channels in high-definition television (HDTV) format. Cable ONE offers voice over Internet Protocol service, which permits users to make voice calls over broadband communications networks, including the Internet.
Other Activities
WaPo Labs is a digital team focusing on experimenting with emerging technologies. In 2012, WaPo Labs launched several projects in partnership with the Company�� media properties: Personal Post, a feature on washingtonpost.com that delivers personalized article recommendations based on a user�� interests and past reading behavior; The Fold, a video news program available on washingtonpost.com, Google TV and Android tablets, and The Root 100, which comprises 100 Android apps aggregating content about the Root 100 honorees, chosen for their impact and influence within the African-American community. In addition to working clo! sely with! the Company�� news websites, WaPo Labs oversees Washington Post Social Reader (Social Reader) and Trove. Social Reader is a Facebook-connected Website that delivers news articles based on a user�� interests and what their friends are reading. Social Reader aggregates content from the Post, Slate, Foreign Policy, Express, the Root and more than 90 other content partners to create a social stream of articles.
Social Code LLC (Social Code) is a marketing solutions company helping Fortune 500 brands maximize their marketing efforts on social media platforms. Celtic Healthcare, Inc. (Celtic) is a Medicare-certified provider of home health and hospice services headquartered in Mars, PA. Through its subsidiaries, Celtic is licensed to provide home health and hospice services throughout Pennsylvania and Maryland. These services include skilled nursing, physical therapy, occupational therapy, speech therapy, social work, nutrition, chaplain and aid services. In addition, Celtic provides virtual care services to patients throughout its service territories. Celtic derives 74% of its revenue from Medicare, with the remaining sources of revenue being Medicaid, commercial insurance and private payors.
The Company competes with Edmunds.com, AutoTrader.com, Realtor.com, Zillow.com, Yelp, OpenTable, Google, Monster.com, CareerBuilder.com and Yahoo!.
Advisors' Opinion:- [By Paul Ausick]
Kaplan booked more than $2 billion in revenues in 2013, down slightly from 2012. Kaplan is owned by Graham Holdings Co. (NYSE: GHC), which was spun out of the Washington Post Co. when Jeff Bezos, CEO of Amazon.com Inc. (NASDAQ: AMZN) bought the newspaper last year
- [By Emily Jane Fox]
In the past year, millennials turned up the heat against low wages at Victoria's Secret, Wal-Mart (WMT, Fortune 500), McDonald's (MCD, Fortune 500), Wendy's (WEN), KFC (YUM, Fortune 500) and others like Kaplan (GHC), which runs tutoring centers.
Best Defensive Companies To Invest In Right Now: Antares Pharma Inc (ATRS)
Antares Pharma, Inc. (Antares) is a pharma company that focuses on self-injection pharmaceutical products and technologies and topical gel-based products. The Company�� subcutaneous and intramuscular injection technology platforms include Vibex disposable pressure-assisted auto injectors, Vision reusable needle-free injectors, and disposable multi-use pen injectors. In the injector area, it has licensed its reusable needle-free injection device for use with human growth hormone (hGH) to Teva, Ferring Pharmaceuticals BV (Ferring) and JCR Pharmaceuticals Co., Ltd. (JCR), with Teva and Ferring being its two primary customers. The Company has also licensed both disposable auto and pen injection devices to Teva for use in certain fields and territories and is engaged in product development activities for Teva utilizing these devices.
In the gel-based area, it received Food and Drug Administration (FDA) approval in December 2011 for its oxybutynin gel 3% product, Anturol, for the treatment of overactive bladder. Antares also has a licensing agreement with Watson Watson Pharmaceuticals, Inc. (Watson) under which Watson will commercialize its topical oxybutynin gel 3% product in the United States and Canada. Its gel portfolio also includes Elestrin (estradiol gel) in the United States for the treatment of moderate-to-severe vasomotor symptoms associated with menopause. Antares has designed disposable, pressure assisted auto injector devices to address acute medical needs, such as allergic reactions, migraine headaches, acute pain, emesis and other daily therapies.
Pressure Assisted Injection Devices
The Company�� Pressure Assisted Injection Devices consists of three products: reusable needle-free injectors, disposable pressure assisted auto injectors and disposable pen injectors. Reusable needle-free injectors deliver precise medication doses through high-speed, pressurized liquid penetration of the skin without a needle. The injector employs a disposable pl! astic needle-free syringe, which offers liquid medication delivery through an opening that is approximately half the diameter of a standard, 30-gauge needle.
Disposable pressure assisted auto injectors is a technology of controlled pressure delivery of drugs into the body utilizing a spring power source. The Vibex is designed to provide fast subcutaneous or intramuscular injections of up to 0.5ml with minimal discomfort and improved convenience in conjunction with the enhanced safety of a shielded needle. Disposable pen injectors are needle-based devices designed to deliver multiple injections from multi-dose drug cartridges. The devices contain mechanisms that specify the dose to be delivered by defining the amount of movement by the stopper in the cartridge with each device actuation.
The Vision/Tjet has been sold for use in more than 30 countries to deliver either insulin or hGH. The product features a reusable, spring-based power source and disposable needle-free syringe, which acts as the pathway for the injectable drug through the skin and allows for viewing of the medication dose prior to injection. The product is also reusable, with each device designed to last for approximately 3,000 injections (or approximately two years) while the needle-free syringe, when used with insulin or hGH, is disposable after approximately one week when used by a single patient for injecting from multi-dose vials. The Vision/Tjet administers injectables by using a spring to push the active ingredient in solution or suspension through a micro-fine opening in the needle-free syringe. The opening is approximately half the diameter of a 30-gauge needle. The Vision/Tjet is primarily used in the United States, Europe, Asia and Japan.
Antares has designed disposable, pressure assisted auto injector devices to address acute medical needs, such as allergic reactions, migraine headaches, acute pain, emesis and other daily therapies. Its Vibex disposable product combines a low-energy, spr! ing-based! power source with a hidden needle, which delivers up to 0.5ml of the needed drug solution subcutaneously or intramuscularly. Antares is also developing a Vibex MTX auto injector for delivery of methotrexate for treatment of rheumatoid arthritis. The Company�� multi use, disposable pen injector complements its portfolio of single-use pressure assisted auto injector devices. The disposable pen injector device is designed to deliver drugs by injection through needles from multi- dose cartridges. The disposable pen is in the stage of development where devices are being used in clinical evaluations.
Transdermal Products
The Company�� ATD system penetrates the skin to deliver a variety of treatments. The gels consist of a hydro-alcoholic base, including a combination of permeation enhancers. Products being developed/ commercialized include Anturol, Elestrin and Nestragel. Elestrin is a transdermal estradiol gel for the treatment of moderate-to-severe vasomotor symptoms associated with menopause. Its other injectable drugs that are presently self-administered and may be suitable for injection with its systems include therapies for the prevention of blood clots and treatments for multiple sclerosis, migraine headaches, inflammatory diseases, impotence, infertility, acquired immune deficiency symdrome (AIDS) and hepatitis.
The Company competes with Ypsomed AG, SHL Group AB, OwenMumford Ltd., West Pharmaceuticals, Becton Dickinson, Haselmeir GmbH, Elcam Medical, Vetter Pharma, Bioject Medical Technologies Inc., The Medical House PLC, Watson, Abbott, Eli Lilly, Auxillium, Inc., Endo Pharmaceuticals, Teva, Mylan, Roxane, Bedford Labs, APP Pharmaceuticals, Hospira, Pfizer, GSK/Astellas, Warner Chilcott and Allergan.
Advisors' Opinion:- [By Luke Jacobi]
Antares Pharma (NASDAQ: ATRS) added 6.65 percent to close at $4.33 following the announcement that an FDA decision is expected on its drug on October 14. Equities
- [By Keith Speights]
Antares Pharma (NASDAQ: ATRS ) announced its first-quarter results �Wednesday morning but failed to impress the market. Shares were down around 3% in midday trading. Here are the highlights from the company's results.
No comments:
Post a Comment